Genedrive Share Discussion Threads

[jock3636] 10/7/2020 08:17

I would strangle your little turkey neck if I could right now get a life

[ostrading2] 10/7/2020 08:15

I wonder how the people who bought this at 180-250p feel seeing this below 100p?Disaster. Covid party is done. Follow the market don't fool yourselves or you'll get hurt.

[ostrading2] 10/7/2020 08:13

Poor numbers. Only £1m orders for their no 1 product... price keeps tanking. Wake up holders, it's been on downwards trajectory for a while now.

[k1ngkonggb] 10/7/2020 08:13

Nice deramp not so helpful....jog on

[helpfull] 10/7/2020 08:11

Wow! The numbers here are astonishing. A major beneficiary of the Covid bubble.There is no substantive revenue. Worryingly, the numbers are all about potential. A total gamble which at the current market capitalisation is frightening.

[amaretto1] 10/7/2020 07:33

It's a hold ... a lot going on .. looks like a few weeks longerFuture looks very promising.Odviously they don't need money, what u talking about buywell ? Can u not read.

[mms98] 09/7/2020 16:11

1.0499 to buy at the mo, even though 1.03 is shown

[blackvulture] 09/7/2020 15:55

M&ms caught with their trousers down nobody selling lid about to pop Blue finish.

[saint in exile] 09/7/2020 14:56

Got to be news soon

[markfrankie] 09/7/2020 14:33

blackvulture avct? directed at me? nope im not in them

[mcrudden] 09/7/2020 14:26

Somethings brewing here, volumes increasing with some chunky buying.

[blackvulture] 09/7/2020 14:22

So why are you invested in AVCT, like me.

[markfrankie] 09/7/2020 14:22

blackvulture, no not a shorter- im not taking as much notice of my little investment here as I should, thanks for info.

[blackvulture] 09/7/2020 13:37

After the 1st of June? Very interesting. The coronavirus took hold slowly in India, but six months after its first confirmed infection it has overtaken Russia to record the world's third largest caseload.With the world's second-largest population, much of which lives packed into cities, the country was perhaps always destined to become a global hotspot.But the data behind its case numbers is questionable, because India is not testing enough, and an unusually low death rate has baffled scientists.Here's five things we know about the spread of coronavirus in India.1. India's cases are rising fastIndia has seen a series of record spikes recently, adding tens of thousands of cases daily. It recorded most of its confirmed cases in June, within weeks of reopening after a rigid lockdown.As of 8 July, India had 742,417 confirmed cases.?But the true scale of infection rates in the population is unclear, according to virologist Shahid Jameel.The government conducted a random sample of 26,000 Indians in May, which showed that 0.73% had the virus. Some experts have reservations about the sample size, but others, such as Dr Jameel, say it's the only country-wide indicator they have to work with."If we extrapolate that to the whole population, we would have had 10 million infections in mid-May," Dr Jameel said.Given that confirmed cases in India have been doubling every 20 days, that would put the current total between 30 and 40 million.The gap between confirmed cases and actual infections exists in every country, but to different degrees. Testing is the only way to bridge it. "If you test more, you will find more," Dr Jameel said.That's what has happened in India in recent weeks - as the government ramped up testing, case numbers suddenly increased.India has done more than 10 million tests since 13 March, but more than half of those happened after 1 June.

[blackvulture] 09/7/2020 13:31

Also don't forget update on the development of the other test.The Company continues to develop a point-of care version of the SARS-CoV-2 test for use with its Genedrive(R) platform, which will enable decentralised testing.

[captain stock] 09/7/2020 13:30

We just need the market to wake up to this now.

[blackvulture] 09/7/2020 13:26

The Genedrive(R) 96 SARS-CoV-2 Kit is a novel Polymerase Chain Reaction (PCR) assay designed to detect active infection in COVID-19 patients. genedrive's PCR bead format eliminates the need for the time consuming and error-prone reagent preparation required in all other open-platform test kits. The proprietary format streamlines laboratory workflow, allowing more tests to be performed in a day. Patient samples are simply mixed with the PCR beads, and are then analysed on a variety of existing third-party real time PCR platforms. During CE-IVD evaluations on 180 randomised specimens, the Genedrive(R) 96 SARS-CoV-2 Kit achieved 100% sensitivity and 98.2% specificity, placing it in a top tier performance table for COVID-19 PCR tests.

[blackvulture] 09/7/2020 12:46

The only thing missing is FDA approval. Are you a shorter by any chance.

[markfrankie] 09/7/2020 12:37

close to placing price